HIFU for the treatment of prostate cancer
Perrini MR, Migliore A, Jefferson T, Cerbo M
Record ID 32013000644
English
Authors' objectives:
To assess whether, based on available evidence, is it possible to provide guidance on the use of HIFU for the treatment of localised prostate cancer within the Italian NHS.
Authors' recommendations:
Evidence from our systematic review did not allow us to make a final statement about the comparative effectiveness of HIFU ablation versus the other options. No RCTs or other comparative studies had been published. Only non-comparative retrospective studies have been published reporting on large groups of patients for long follow-up periods. We believe that the lack of trials is the main problem in the field of medical devices and surgical interventions assessment. Although a specific reimbursement fee for the HIFU procedure does not exist, the technology is widely used in Italy. We suggest considering HIFU as an investigational treatment since the mechanisms of action and short-term effectiveness are already known but long-term comparative data are expected.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.salute.gov.it/imgs/C_17_pagineAree_1202_listaFile_itemName_14_file.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Italy
MeSH Terms
- Humans
- High-Intensity Focused Ultrasound Ablation
- Prostatic Neoplasms
Contact
Organisation Name:
The Italian National Agency for Regional Health Services (Agenas)
Contact Address:
Agenzia nazionale per i servizi sanitari regionali, Via Puglie 23, 00187 Rome, Italy
Contact Name:
hta@agenas.it
Contact Email:
hta@agenas.it
Copyright:
Italian Ministry of Health and Agenas
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.